Cytokinetics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Amgen USD 1.69B 191M 2025-03
Bayer EUR 3.71B 628M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Cytokinetics USD 57.37M 4.97M 2025-03
Eisai JPY 106.51B 1.99B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Exelixis USD 137.18M 2.86M 2025-04
Geron USD 40.02M 3.35M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.22B 980M 2025-03



Cytokinetics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.